Discussion on "Estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie Davidian

Biometrics. 2022 Sep;78(3):839-840. doi: 10.1111/biom.13540. Epub 2021 Aug 22.

Author

M Elizabeth Halloran^{1

2}

Affiliations

¹ Biostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
² Department of Biostatistics, University of Washington, Seattle, Washington, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Randomized Controlled Trials as Topic
Vaccine Efficacy*

Grants and funding

R37 AI032042/AI/NIAID NIH HHS/United States